Skip to main content
SpringerLink
Log in
Book cover

Interferon: The Dawn of Recombinant Protein Drugs

  • Conference proceedings
  • © 1999

Overview

Editors:
  1. J. Lindenmann

    1. Gockhausen, Switzerland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. W.-D. Schleuning

    1. Schering AG, Berlin, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Ernst Schering Foundation Symposium Proceedings (SCHERING FOUND, volume 5)

Part of the book sub series: Schering Foundation Symposium Proceedings Supplements (3368)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (7 papers)

  1. Front Matter

    Pages I-XIV
    Download chapter PDF

  2. Is There Life Without Interferon?

    • N. B. Finter
    Pages 1-14

  3. What Constitutes Therapeutic Success? The Interferons (1978–1998)

    • T. Pieters
    Pages 15-31

  4. The Prehistory and History of the Uses of Interleukin-2 in Cancer Therapy

    • I. Löwy
    Pages 33-68

  5. Interferon-α: From Pass Interference to Cytokine Networking

    • P. Fitzgerald-Bocarsly
    Pages 69-88

  6. A Biosemiotic View of Interferon: Toward a Biology of Really Living Organisms

    • Y. Kawade
    Pages 89-106

  7. The Clinical and Social Impact of Interferon-β: The First Approved Therapy in Multiple Sclerosis

    • H. F. McFarland
    Pages 107-119

  8. Interferon: The Dawn of Recombinant Protein Drugs

    • J. Lindenmann, W.-D. Schleuning
    Pages 121-134

  9. Back Matter

    Pages 135-138
    Download chapter PDF
Back to top

Keywords

About this book

Forty years of Interferon I wish to dedicate this short introduction to the memory of Alick Isaacs (1921-1967), and to that of Sir Christopher Andrewes (1896-1988). Let us go back more than 40 years. In 1956 Isaacs was in charge of the Wodd Influenza Centre. Andrewes was head of the division of bac­ teriology and virology, and deputy director of the National Institute for Medical Research in London. When researchers are faced with a seemingly new phenomenon, ex­ planations are easy to come by. These explanations fall into two broad categories: the phenomenon in question is either due to something or to the lack of something. I apologize for the primitive way in which I ex­ press this, but I am going to give three examples, scattered over 100 years, of what I mean. First example: in 1880 the great French microbiologist Louis Pas­ teur was involved in work on chicken cholera. He was struck by the following observation: if a suitable chicken broth was inoculated with the bacterium, the organism grew profusely and the liquid became tur­ bid. If he now freed the fluid, by sedimentation or filtration, from the bulk of the organisms and re-inoculated it with the same bacterium, no growth occurred.

Editors and Affiliations

  • Gockhausen, Switzerland

    J. Lindenmann

  • Schering AG, Berlin, Germany

    W.-D. Schleuning

Bibliographic Information

  • Book Title: Interferon: The Dawn of Recombinant Protein Drugs

  • Editors: J. Lindenmann, W.-D. Schleuning

  • Series Title: Ernst Schering Foundation Symposium Proceedings

  • DOI: https://doi.org/10.1007/978-3-662-03787-4

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1999

  • Softcover ISBN: 978-3-662-03789-8Published: 03 October 2013

  • eBook ISBN: 978-3-662-03787-4Published: 29 June 2013

  • Series ISSN: 0947-6075

  • Edition Number: 1

  • Number of Pages: XIV, 138

  • Number of Illustrations: 2 b/w illustrations

  • Topics: Pharmacology/Toxicology, Immunology, Biotechnology

Publish with us

Policies and ethics

Back to top

Search

Navigation